Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Gynecologic Oncology, 1(99), p. 20-25

DOI: 10.1016/j.ygyno.2005.05.042

Links

Tools

Export citation

Search in Google Scholar

Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer

Journal article published in 2005 by John K. Chan, Chan Jk, Alessandra Magistris, Vera Loizzi ORCID, Fritz Lin, Joanne Rutgers, Kathryn Osann, Philip J. DiSaia, DiSaia Pj, Michael Samoszuk
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Objective. To determine clinical or biological associations between mast cell density, blood clotting, angiogenesis, and survival of patients with advanced ovarian cancer. Methods. Tumor tissue sections were assessed for mast cell density by staining for mast cell tryptase, blood clotting by staining of thrombosed blood vessels, and angiogenesis by CD34 expression. Chi-square, Kaplan-Meier, and Cox proportional hazard statistical analyses were used. Results. 44 women with stage III-IV ovarian cancers had tumor blocks available for immunohistochemical analysis. Higher mean vessel density (MVD) (> 11 vessels/400x field) predicted for better survival than lower MVD (